myocardial infarction

Summary

Summary: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Top Publications

  1. Fournier S, Muller O, Ludman A, Lauriers N, Eeckhout E. Influence of socioeconomic factors on delays, management and outcome amongst patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Swiss Med Wkly. 2013;143:w13817 pubmed publisher
    The outcome after primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) is strongly affected by time delays...
  2. Benyamini Y, Roziner I, Goldbourt U, Drory Y, Gerber Y. Depression and anxiety following myocardial infarction and their inverse associations with future health behaviors and quality of life. Ann Behav Med. 2013;46:310-21 pubmed publisher
    Post-myocardial infarction (MI) depression and anxiety were found to predict prognosis and quality of life. The purpose of this study was to test a behavioral pathway from post-MI depression/anxiety to future quality of life...
  3. Denollet J, Freedland K, Carney R, De Jonge P, Roest A. Cognitive-affective symptoms of depression after myocardial infarction: different prognostic importance across age groups. Psychosom Med. 2013;75:701-8 pubmed publisher
    Cognitive-affective symptoms of depression may not be as strongly related to prognosis after myocardial infarction (MI) as somatic depressive symptoms...
  4. Fox K, Bousser M, Amarenco P, Chamorro A, Fisher M, Ford I, et al. Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansien. Int J Cardiol. 2013;168:3500-5 pubmed publisher
    ..We analyzed the effect of baseline resting heart rate on myocardial infarction (MI) in patients with a recent noncardioembolic cerebral ischemic event participating in PERFORM...
  5. Ferraro S, Biganzoli E, Marano G, Santagostino M, Boracchi P, Panteghini M, et al. New insights in the pathophysiology of acute myocardial infarction detectable by a contemporary troponin assay. Clin Biochem. 2013;46:999-1006 pubmed publisher
    ST-elevation and non-ST-elevation myocardial infarction (STEMI, NSTEMI) are considered two distinct pathophysiologic entities...
  6. Herrett E, Shah A, Boggon R, Denaxas S, Smeeth L, van Staa T, et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ. 2013;346:f2350 pubmed publisher
    To determine the completeness and diagnostic validity of myocardial infarction recording across four national health record sources in primary care, hospital care, a disease registry, and mortality register. Cohort study...
  7. Serruys P, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, et al. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (. JACC Cardiovasc Interv. 2013;6:777-89 pubmed publisher
    ..The primary endpoint was a composite of cardiac death, myocardial infarction (MI), or clinically indicated target vessel revascularization within 9 months...
  8. Seropian I, Toldo S, Van Tassell B, Abbate A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593-603 pubmed publisher
    Acute myocardial infarction (AMI) leads to molecular, structural, geometric, and functional changes in the heart in a process known as ventricular remodeling...
  9. Sahoo S, Losordo D. Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014;114:333-44 pubmed publisher
    b>Myocardial infarction is a leading cause of death among all cardiovascular diseases...

More Information

Publications32

  1. Moon H, Joo M, Mok H, Lee M, Hwang K, Kim S, et al. MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. Biomaterials. 2014;35:1744-54 pubmed publisher
    ..hypoxia-inducible vascular endothelial growth factor gene (pHI-VEGF) in MSCs for the treatment of rat myocardial infarction. Under the optimized transfection conditions, the BA-PEI conjugates significantly increased the VEGF ..
  2. Bathgate Siryk A, Dabul S, Pandya K, Walklett K, Rengo G, Cannavo A, et al. Negative impact of ?-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension. 2014;63:404-12 pubmed publisher
    ..Herein, we sought to delineate specific roles of ?arr1 in post-myocardial infarction (MI) HF by testing the effects of ?arr1 genetic deletion on normal and post-MI cardiac function and ..
  3. Chen J, Hsieh A, Dharmarajan K, Masoudi F, Krumholz H. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation. 2013;128:2577-84 pubmed publisher
    ..studies have reported conflicting findings regarding how the incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time, and data on contemporary national trends are sparse...
  4. Chu S, Chen Y, Liu C, Tseng W, Lin M, Hwang C, et al. Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med. 2013;126:982-8 pubmed publisher
    ..Nevertheless, there have been no large-scale epidemiological studies about the risk of acute myocardial infarction in patients with systemic sclerosis...
  5. Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, et al. The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism. 2014;63:127-36 pubmed publisher
    ..of diets on cardiovascular function, energy metabolism and potential risk of heart damage in case of myocardial infarction. The objective of the present study was to investigate whether the increased level of glucose oxidation or ..
  6. Gaigalaite V, Ozheraĭtene V, Kalibatene D, Laurikenas K, Sabaliauskene Z. [Association between structure of atherosclerotic plaques in carotid arteries and myocardial infarction]. Kardiologiia. 2013;53:21-5 pubmed
    ..to investigate association between structure of atherosclerotic plaque (AP) in internal carotid artery and myocardial infarction (MI), as well as to elucidate factors which may determine expansion of APs into coronary arteries...
  7. Artang R, Rome E, Nielsen J, Vidaillet H. Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors. Am J Cardiol. 2013;112:1973-9 pubmed publisher
    Dabigatran has been associated with greater risk of myocardial infarction (MI) than warfarin...
  8. Jneid H, Alam M, Virani S, Bozkurt B. Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction?. Methodist Debakey Cardiovasc J. 2013;9:169-72 pubmed
    b>Myocardial infarction (MI) is a major cause of mortality and morbidity worldwide. Each year, an estimated 785,000 persons will have a new MI in the United States alone, and approximately every minute an American will succumb to one...
  9. Wang F, Long G, Zhao C, Li H, Chaugai S, Wang Y, et al. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med. 2013;11:222 pubmed publisher
    ..However, the dynamic change of circulating miR-133a level in the early phase of acute myocardial infarction (AMI) and the correlation between miR-133a and severity of coronary stenosis in coronary heart disease (..
  10. Chan H, Ke L, Chu C, Lee A, Shen M, Cruz M, et al. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood. 2013;122:3632-41 pubmed publisher
    Platelet activation and aggregation underlie acute thrombosis that leads to ST-elevation myocardial infarction (STEMI). L5-highly electronegative low-density lipoprotein (LDL)-is significantly elevated in patients with STEMI...
  11. Huang S, Chan W, Leu H, Huang P, Chen J, Lin S. Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction. PLoS ONE. 2013;8:e74709 pubmed publisher
    New-onset atrial fibrillation (AF) commonly occurs in patients with acute myocardial infarction (AMI). Data regarding the value of the CHADS2 score in patients hospitalized for AMI is limited...
  12. Kim H, No C, Goo S, Cha T. An Angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model. J Korean Med Sci. 2013;28:700-8 pubmed publisher
    ..of angiotensin II receptor blocker in atrial remodeling in rats with atrial fibrillation (AF) induced by a myocardial infarction (MI). MIs were induced by a ligation of the left anterior descending coronary artery...
  13. Izquierdo M, Ruiz Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, et al. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2013;6:755-61 pubmed publisher
    ..Its value soon after an acute ST-segment-elevation myocardial infarction remains unknown...
  14. Wang Y, Liu J, Suo F, Hu H, Xue M, Cheng W, et al. Metoprolol-mediated amelioration of sympathetic nerve sprouting after myocardial infarction. Cardiology. 2013;126:50-8 pubmed publisher
    ..Metoprolol can prevent sympathetic nerve remodeling after myocardial infarction (MI), but the underlying mechanism is unclear...
  15. Phung O, Schwartzman E, Allen R, Engel S, Rajpathak S. Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis. Diabet Med. 2013;30:1160-71 pubmed publisher
    ..27, 95% confidence interval 1.18-1.34, n = 27 comparisons) and composite cardiovascular event (including myocardial infarction, stroke, cardiovascular-related hospitalization or cardiovascular death) (relative risk 1...
  16. Sebbane M, Lefebvre S, Kuster N, Jreige R, Jacques E, Badiou S, et al. Early rule out of acute myocardial infarction in ED patients: value of combined high-sensitivity cardiac troponin T and ultrasensitive copeptin assays at admission. Am J Emerg Med. 2013;31:1302-8 pubmed publisher
    We sought to evaluate the added value of ultrasensitive copeptin (us-copeptin) for early rule out of acute myocardial infarction in a prospective cohort of emergency department (ED) patients with acute chest pain...
  17. Wen Z, Cai M, Mai Z, Jin D, Chen Y, Huang H, et al. Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction. PLoS ONE. 2013;8:e67242 pubmed publisher
    The mechanisms and mediators underlying common renal impairment after myocardial infarction (MI) are still poorly understood...
  18. Modig K, Andersson T, Drefahl S, Ahlbom A. Age-specific trends in morbidity, mortality and case-fatality from cardiovascular disease, myocardial infarction and stroke in advanced age: evaluation in the Swedish population. PLoS ONE. 2013;8:e64928 pubmed publisher
    ..This nationwide cohort study presents age specific trends of CVD as well as for myocardial infarction (MI) and stroke separately for the period 1994 to 2010 for individuals 85 to 99 years old in Sweden...
  19. Nordström P, Religa D, Wimo A, Winblad B, Eriksdotter M. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J. 2013;34:2585-91 pubmed publisher
    ..This study evaluated the use of ChEIs and the later risk of myocardial infarction and death...
  20. Kumbhani D, Bavry A, Desai M, Bangalore S, Bhatt D. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol. 2013;62:1409-18 pubmed publisher
    ..The clinical efficacy of thrombectomy in acute myocardial infarction (AMI) remains uncertain...
  21. He H, Wang S, Li X, Wang H, Zhang W, Yuan L, et al. A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction. Metabolism. 2013;62:1357-66 pubmed publisher
    After acute myocardial infarction (AMI), an integral evaluation of risk using multimarker approach and the understanding of the pathophysiological processes involved have recently received much attention...
  22. Knudsen A, Møller H, Katzenstein T, Gerstoft J, Obel N, Kronborg G, et al. Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study. BMC Infect Dis. 2013;13:230 pubmed publisher
    ..virus (HIV)-infected individuals and has therefore been suggested as a predictive biomarker of myocardial infarction (MI)...
  23. Bi H, Yang Y, Huang J, Li Y, Ma C, Cong B. Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol. 2013;8:84 pubmed publisher
    Sudden cardiac death resulting from acute myocardial infarction (AMI) constitutes a significant percentage of the caseload for forensic and clinical pathologists...